Acadia Healthcare Now Covered by Cantor Fitzgerald (ACHC)
Several other analysts have also recently commented on the stock. Analysts at Zacks downgraded shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating in a research note to investors on Tuesday, February 26th. They now have a $28.50 price target on the stock. Separately, analysts at Raymond James raised their price target on shares of Acadia Healthcare from $27.00 to $30.00 in a research note to investors on Friday, February 22nd. Finally, analysts at BMO Capital Markets reiterated an “outperform” rating on shares of Acadia Healthcare in a research note to investors on Friday, February 22nd. They now have a $34.00 price target on the stock, up previously from $27.00.
Seven research analysts have rated the stock with a buy rating, three have assigned an overweight rating, and one has issued a hold rating to the stock. The company currently has an average rating of “buy” and an average price target of $30.45.
Shares of Acadia Healthcare traded up 0.04% during mid-day trading on Tuesday, hitting $28.04. Acadia Healthcare has a 52 week low of $14.40 and a 52 week high of $28.50. The stock’s 50-day moving average is currently $26.49. The company has a market cap of $1.408 billion and a P/E ratio of 53.19.
Acadia Healthcare Company, Inc. is a provider of inpatient behavioral health care services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.